Danaher Co. (NYSE:DHR) Stock Position Lowered by Financial Enhancement Group LLC

Financial Enhancement Group LLC lowered its position in shares of Danaher Co. (NYSE:DHR) by 6.1% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 10,408 shares of the conglomerate’s stock after selling 673 shares during the quarter. Financial Enhancement Group LLC’s holdings in Danaher were worth $2,497,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. CHURCHILL MANAGEMENT Corp boosted its holdings in Danaher by 2.9% during the fourth quarter. CHURCHILL MANAGEMENT Corp now owns 51,111 shares of the conglomerate’s stock worth $11,732,000 after buying an additional 1,460 shares in the last quarter. Apella Capital LLC lifted its position in shares of Danaher by 6.9% during the 4th quarter. Apella Capital LLC now owns 2,142 shares of the conglomerate’s stock valued at $492,000 after acquiring an additional 138 shares during the last quarter. Thurston Springer Miller Herd & Titak Inc. boosted its stake in shares of Danaher by 33.9% during the 4th quarter. Thurston Springer Miller Herd & Titak Inc. now owns 4,662 shares of the conglomerate’s stock worth $1,070,000 after acquiring an additional 1,181 shares in the last quarter. Park Avenue Securities LLC grew its holdings in shares of Danaher by 15.2% in the 4th quarter. Park Avenue Securities LLC now owns 26,793 shares of the conglomerate’s stock worth $6,150,000 after acquiring an additional 3,540 shares during the last quarter. Finally, Fifth Third Wealth Advisors LLC raised its position in shares of Danaher by 9.2% during the fourth quarter. Fifth Third Wealth Advisors LLC now owns 6,990 shares of the conglomerate’s stock worth $1,605,000 after purchasing an additional 591 shares during the period. 79.05% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on the company. Robert W. Baird dropped their price target on Danaher from $278.00 to $277.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 23rd. Bank of America raised shares of Danaher from a “neutral” rating to a “buy” rating and set a $290.00 target price on the stock in a research report on Friday, December 13th. Stifel Nicolaus boosted their price target on shares of Danaher from $250.00 to $265.00 and gave the company a “hold” rating in a report on Wednesday, October 23rd. UBS Group lowered their price objective on shares of Danaher from $309.00 to $305.00 and set a “buy” rating on the stock in a research report on Wednesday, October 23rd. Finally, Stephens restated an “overweight” rating and issued a $315.00 target price on shares of Danaher in a report on Wednesday, October 23rd. Six investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $286.80.

Danaher Price Performance

NYSE DHR opened at $237.78 on Thursday. The company has a quick ratio of 1.01, a current ratio of 1.37 and a debt-to-equity ratio of 0.32. The stock has a market capitalization of $171.74 billion, a PE ratio of 45.38, a price-to-earnings-growth ratio of 4.23 and a beta of 0.83. Danaher Co. has a 12-month low of $222.53 and a 12-month high of $281.70. The company has a 50 day moving average price of $235.27 and a two-hundred day moving average price of $253.56.

Danaher (NYSE:DHR) last released its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.57 by $0.14. The business had revenue of $5.80 billion during the quarter, compared to analyst estimates of $5.59 billion. Danaher had a net margin of 16.39% and a return on equity of 10.62%. Danaher’s quarterly revenue was up 3.1% compared to the same quarter last year. During the same quarter in the previous year, the business earned $2.02 EPS. As a group, equities analysts predict that Danaher Co. will post 7.49 earnings per share for the current fiscal year.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Friday, December 27th will be issued a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.45%. The ex-dividend date of this dividend is Friday, December 27th. Danaher’s dividend payout ratio is 20.61%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.